addenda and errata
3-(tert-Butoxycarbonyl)-2-(4-chlorophenyl)-1,3-thiazolidine-4-carboxylic acid. Corrigendum
aState Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, People's Republic of China, bSchool of Bioengineering, Zhejiang Chinese Medical University, Hangzhou 310053, People's Republic of China, and cSchool of Chemical Engineering, Changzhou University, Changzhou 213164, People's Republic of China
*Correspondence e-mail: hailiang_zhu@163.com
The author list in the paper by Ding [Acta Cryst. (2010), E66, o2633] is corrected.
References
Ding, S.-M. (2010). Acta Cryst. E66, o2633. Web of Science CSD CrossRef IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.